Proton Beam Therapy for Aged Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 805-812

  Hata, Masaharu ^a,b,c   Tokuuye, Koichi ^a,b   Sugahara, Shinji ^b   Tohno, Eriko ^b   Nakayama, Hidetsugu ^a,b   Fukumitsu, Nobuyoshi ^a,b   Mizumoto, Masashi ^b   Abei, Masato ^b   Shoda, Junichi ^b   Minami, Manabu ^b   Akine, Yasuyuki ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced age; Dose volume analysis; Hepatocellular carcinoma; Proton beam therapy; Radiation therapy

Indexed keywords

DISEASES; DOSIMETRY; ONCOLOGY; PROTON BEAMS; TOXICITY; TUMORS;

DOSE VOLUME ANALYSIS; HEPATOCELLULAR CARCINOMA (HCC); PROTON BEAM THERAPY; TUMOR CONTROL;

RADIOTHERAPY;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DEATH; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; INJURY; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG METASTASIS; MALE; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR VOLUME;

AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; PROTONS; RADIOTHERAPY DOSAGE; TREATMENT FAILURE;

EID: 34548675575     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.016     Document Type: Article

References (43)

1. McGlynn K.A., and London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19 (2005) 3-23
2. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225-235
3. Hsu C., Cheng J.C., and Cheng A.L. Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. J Formos Med Assoc 103 (2004) 483-495
4. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
5. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: A retrospective and nationwide survey in Japan. Hepatology 32 (2000) 1224-1229
6. Chiba T., Tokuuye K., Matsuzaki Y., et al. Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin Cancer Res 11 (2005) 3799-3805
7. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104 (2005) 794-801
8. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 107 (2006) 591-598
9. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 182 (2006) 713-720
10. Hashimoto T., Tokuuye K., Fukumitsu N., et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 196-202
11. Suit H., Goldberg S., Niemierko A., et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 42 (2003) 800-808
12. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
13. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
14. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
15. Inada T., Hayakawa Y., Ohara K., et al. Treatment planning system for high energy proton beam. Nippon Acta Radiol 43 (1983) 781-793
16. Tsunashima Y., Sakae T., Shioyama Y., et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 951-958
17. Ando K., Koike S., Kawachi K., et al. Relative biological effectiveness of the therapeutic proton beam at NIRS and Tsukuba University. Nippon Acta Radiol 45 (1985) 531-535
18. Withers H.R., Thames Jr. H.D., and Peters L.J. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1 (1983) 187-191
19. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
20. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
21. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
22. Altman D.G. Practical statistics for medical research. 2nd ed. (2004), Chapman and Hall, London
23. Japan Ministry of Health, Labour and Welfare. Statistic and other data. Vital statistics. Available at: http://www.mhlw.go.jp/english/database/db-hw/index.html. Accessed February 22, 2007.
24. Lopez P.M., Villanueva A., and Llovet J.M. Systematic review: Evidence-based management of hepatocellular carcinoma-An updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23 (2006) 1535-1547
25. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
26. Llovet J.M., Real M.I., Montaña X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet 359 (2002) 1734-1739
27. Bruix J., Sala M., and Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (2004) S179-S188
28. Sala M., Llovet J.M., Vilana R., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360
29. World Health Organization. The world health report 2006. Available at: http://www.who.int/whr/2006/en/. Accessed February 22, 2007.
30. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
31. Nagasue N., Yukaya H., Hamada T., et al. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 54 (1984) 1461-1465
32. Tsukioka G., Kakizaki S., Sohara N., et al. Hepatocellular carcinoma in extremely elderly patients: An analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol 12 (2006) 48-53
33. Dohmen K., Shirahama M., Shigematsu H., et al. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 19 (2004) 859-865
34. Park W., Lim do H., Paik S.W., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
35. Liu M.T., Li S.H., Chu T.C., et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34 (2004) 532-539
36. Seong J., Park H.C., Han K.H., et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55 (2003) 329-336
37. Uno T., Itami J., Shiina T., et al. Radiation therapy in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 31 Suppl. (1992) S106-S110
38. Park H.C., Seong J., Han K.H., et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
39. Cheng S.H., Lin Y.M., Chuang V.P., et al. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 1025-1033
40. Greco C., Catalano G., Di Grazia A., et al. Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy. Tumori 90 (2004) 73-79
41. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
42. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 (2001) 240-246
43. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283